Results 181 to 190 of about 19,061 (206)

Comparative Gastrointestinal Safety of Dulaglutide, Semaglutide, and Tirzepatide in Adults With Type 2 Diabetes. [PDF]

open access: yesAnn Intern Med
Crisafulli S   +10 more
europepmc   +1 more source

Interventional Pharmacoeconomics

The Cancer Journal, 2020
Abstract The increasing cost of health care is a major challenge around the world, but particularly in the United States. One reason for increased costs is the rapidly rising cost of oncology drugs. Potential solutions to this problem involve broad changes to health policy. However, an alternative solution is the development of lower-cost off-
Daniel A, Goldstein   +5 more
openaire   +2 more sources

Pharmacoeconomics and Aging

Drugs & Aging, 2009
The aging of the general population in industrialized countries has brought to public attention the increasing incidence of age-related clinical conditions, because the long-term impact of diseases on functional status and on costs are greater in older people than in any other age group.
Bustacchini, S.   +6 more
openaire   +3 more sources

Pharmacoeconomics

Current Opinion in Gastroenterology, 1996
Eradication of Helicobacter pylori offers the potential of cost savings in combination with better outcomes over intermittent or maintenance therapy of duodenal ulcer disease. Treatment regimes that give a higher eradication rate are cost-effective despite higher costs.
Deltenre, Michel Arthur, Jönsson, Bengt
openaire   +1 more source

Pharmacoeconomics

2018
Although pharmacoeconomic justifications often examine dollars spent or lives saved, the implications for the health of communities are equally important. Given the significant and growing cost of health care and medications, decision-makers face the difficult dilemma of choosing how best to optimize resources efficiently and effectively (relating to ...
Scott K Griggs, Peter Hurd
  +4 more sources

Pharmacoeconomic considerations

American Journal of Health-System Pharmacy, 2003
Pharmacoeconomic analyses can be readily applied to the study of venous thromboembolism (VTE) in the orthopedic postsurgical setting. The cost of VTE to the health care system and a cost-effectiveness trial that utilized a factor Xa inhibitor for VTE prophylaxis are discussed.
openaire   +2 more sources

Pharmacoeconomic research

Pharmacy World & Science, 2003
Efficacy and safety are crucial considerations in judging drugs, for example, whether or not to include them in a local formulary. More and more, pharmacoeconomic aspects are becoming of additional importance. How should we interpret such pharmacoeconomic studies?
openaire   +3 more sources

Home - About - Disclaimer - Privacy